Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00170378
Status:
COMPLETED
Last Update Posted:
2017-06-27
First Post:
2005-09-12
Brief Title:
The Use of Low Molecular Weight Heparin in Traumatic Brain Injury
Sponsor:
Hennepin Healthcare Research Institute
Organization:
Hennepin Healthcare Research Institute
Study Overview
Official Title:
The Use of Low Molecular Weight Heparin in Traumatic Brain Injury
Status:
COMPLETED
Status Verified Date:
2012-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To study the safety and efficacy of early administration of Low Molecular Weight Heparin to patients with traumatic brain injury
Detailed Description:
Venous thromboembolic VTE prophylaxis in trauma patients is a critical clinical problem Patients with traumatic brain injury usually have effective VTE prophylaxis withheld secondary to concerns of exacerbating intracranial hemorrhage This study examines the safety and efficacy of early administration within 24 hrs of admission of low molecular weight heparin to this patient population with very high VTE risk
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None